The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Rodman David Malcom since year 2005.
The trader's CIK number is 1672659.
At the time of this reporting, Rodman David Malcom is the Exec Vice President and CMO of Nivalis Therapeutics, Inc. .
(stock ticker symbol NVLS).
See this page for all insider trading activities at Nivalis Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-01-04||NVLS||Nivalis Therapeutics, Inc.||Sale||6,687||2.27||15,179|
|2017-01-03||NVLS||Nivalis Therapeutics, Inc.||Option Ex||18,055||.00||0|
|2016-10-04||NVLS||Nivalis Therapeutics, Inc.||Sale||5,820||7.96||46,327|
|2016-10-03||NVLS||Nivalis Therapeutics, Inc.||Option Ex||18,056||.00||0|
|2016-07-01||NVLS||Nivalis Therapeutics, Inc.||Option Ex||18,055||.00||0|
|2016-07-05||NVLS||Nivalis Therapeutics, Inc.||Sale||5,950||4.66||27,727|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rodman David Malcom (Exec Vice President and CMO of Nivalis Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.